Tumores neuroendocrinos: impacto de LANREÓTIDA en la supervivencia de la enfermedad estable y progresiva - page 1

TUMORES NEUROENDOCRINOS: IMPACTO DE

LANREÓTIDA EN LA SUPERVIVENCIA DE LA

ENFERMEDAD ESTABLE Y PROGRESIVA

Jaume Capdevila

GI and Endocrine Tumor Unit

Vall d’Hebron University Hospital

Vall d’Hebron Institute of Oncology (VHIO)

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1 2,3,4,5,6,7,8,9,10,11,...26